Sotera Health Company $SHC Shares Bought by Principal Financial Group Inc.

Principal Financial Group Inc. grew its position in Sotera Health Company (NASDAQ:SHC) by 16.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 520,209 shares of the company’s stock after buying an additional 74,217 shares during the period. Principal Financial Group Inc.’s holdings in Sotera Health were worth $7,460,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Sculptor Capital LP raised its position in shares of Sotera Health by 57.4% during the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after buying an additional 7,658,200 shares during the period. Vanguard Group Inc. increased its stake in Sotera Health by 16.7% during the fourth quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after acquiring an additional 2,756,583 shares during the last quarter. Sachem Head Capital Management LP increased its stake in Sotera Health by 47.2% during the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after acquiring an additional 3,735,000 shares during the last quarter. Janus Henderson Group PLC raised its position in Sotera Health by 4.8% in the fourth quarter. Janus Henderson Group PLC now owns 6,772,059 shares of the company’s stock valued at $119,460,000 after purchasing an additional 312,191 shares during the period. Finally, State Street Corp raised its position in Sotera Health by 21.0% in the fourth quarter. State Street Corp now owns 5,965,326 shares of the company’s stock valued at $105,228,000 after purchasing an additional 1,035,457 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Wall Street Zen cut Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Barclays boosted their price objective on shares of Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Piper Sandler reaffirmed an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 price target for the company. Finally, Weiss Ratings raised shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $17.35 on Monday. The stock has a market capitalization of $4.95 billion, a price-to-earnings ratio of 42.32 and a beta of 1.76. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. The business has a 50-day moving average of $16.65 and a 200 day moving average of $16.38. Sotera Health Company has a 12 month low of $11.00 and a 12 month high of $19.85.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The company had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, sell-side analysts forecast that Sotera Health Company will post 0.87 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 15.36% of the stock is currently owned by insiders.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.